HUT61467A - Process for producing pharmaceutical compositions comprising quisqualate receptor antagonist quinoxalinedione and suitable for treating parkinson's disease - Google Patents
Process for producing pharmaceutical compositions comprising quisqualate receptor antagonist quinoxalinedione and suitable for treating parkinson's diseaseInfo
- Publication number
- HUT61467A HUT61467A HU922990A HUP9202990A HUT61467A HU T61467 A HUT61467 A HU T61467A HU 922990 A HU922990 A HU 922990A HU P9202990 A HUP9202990 A HU P9202990A HU T61467 A HUT61467 A HU T61467A
- Authority
- HU
- Hungary
- Prior art keywords
- disease
- quinoxalinedione
- pharmaceutical compositions
- receptor antagonist
- treating parkinson
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19904041981 DE4041981A1 (de) | 1990-12-21 | 1990-12-21 | Neue verwendung von quisqualat-rezeptor-antagonisten |
DE19914121483 DE4121483A1 (de) | 1991-06-26 | 1991-06-26 | Neue verwendung von quisqualat-rezeptor-antagonisten |
Publications (2)
Publication Number | Publication Date |
---|---|
HU9202990D0 HU9202990D0 (en) | 1992-12-28 |
HUT61467A true HUT61467A (en) | 1993-01-28 |
Family
ID=25899840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU922990A HUT61467A (en) | 1990-12-21 | 1991-12-20 | Process for producing pharmaceutical compositions comprising quisqualate receptor antagonist quinoxalinedione and suitable for treating parkinson's disease |
Country Status (12)
Country | Link |
---|---|
US (1) | US6191132B1 (hu) |
EP (1) | EP0516795B1 (hu) |
JP (1) | JPH05505830A (hu) |
AT (1) | ATE180405T1 (hu) |
AU (1) | AU655958B2 (hu) |
CA (1) | CA2076524A1 (hu) |
DE (1) | DE59109130D1 (hu) |
HU (1) | HUT61467A (hu) |
IE (1) | IE914526A1 (hu) |
IL (1) | IL100458A (hu) |
PT (1) | PT99864B (hu) |
WO (1) | WO1992011012A1 (hu) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE404201T1 (de) * | 1992-06-22 | 2008-08-15 | Univ California | Glycinrezeptorantagonisten und ihre verwendung |
US5631373A (en) * | 1993-11-05 | 1997-05-20 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones |
HUP0001311A3 (en) * | 1997-02-18 | 2001-07-30 | American Home Products Corp Ma | 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists and pharmaceutical compositions containing them |
US5922715A (en) * | 1997-02-18 | 1999-07-13 | American Home Products Corporation | 5-aminoalkoxy-1, 4-dihydroquinoxaline-2, 3-diones |
DE10043321B4 (de) * | 2000-08-24 | 2005-07-28 | Neurobiotec Gmbh | Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung |
DE10053397A1 (de) | 2000-10-20 | 2002-05-02 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
DE10064453A1 (de) * | 2000-12-16 | 2002-07-04 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
WO2004110255A2 (en) | 2003-06-09 | 2004-12-23 | Gang Zheng | Antineoplastic agents targeted via glut transporters |
JPWO2006109876A1 (ja) * | 2005-04-08 | 2008-11-20 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 不随意運動治療剤 |
WO2009054544A1 (en) * | 2007-10-26 | 2009-04-30 | Eisai R & D Management Co., Ltd. | Ampa receptor antagonists for parkinson's disease and movement disorders |
EP2338492A1 (en) * | 2009-12-24 | 2011-06-29 | Universidad del Pais Vasco | Methods and compositions for the treatment of alzheimer |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5852219A (ja) * | 1981-09-22 | 1983-03-28 | Sumitomo Chem Co Ltd | パ−キンソン病治療剤 |
IE66149B1 (en) * | 1986-09-16 | 1995-12-13 | Novo Nordisk As | Quinoxaline compounds and their preparation and use |
US4812458A (en) * | 1986-09-16 | 1989-03-14 | A/S Ferrosan | 6,7-disubstituted-2,3-dihydroxyquinoxaline compounds, pharmaceutical compositions thereof, and their use as neuroleptics |
DK146787A (da) | 1987-03-23 | 1988-09-24 | Ferrosan | Heterocykliske forbindelser, deres fremstilling og anvendelse |
NO179551C (no) | 1987-11-10 | 1996-10-30 | Novo Nordisk As | Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser |
DK160941C (da) | 1988-06-28 | 1991-10-21 | Novo Nordisk As | Kondenserede 2,3-dihydroxypyraziner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater, hvori forbindelserne indgaar |
DK338789A (da) * | 1988-07-15 | 1990-01-16 | Schering Ag | 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf |
DK715888D0 (da) | 1988-12-22 | 1988-12-22 | Ferrosan As | Quinoxalinforbindelser, deres fremstilling og anvendelse |
US4975430A (en) * | 1989-06-16 | 1990-12-04 | The State Of Oregon Acting By And Through The State Board Of Education On Behalf Of The Oregon Health Sciences University | CNQX and its analogs as therapeutics for degenerative neural diseases |
-
1991
- 1991-12-19 PT PT99864A patent/PT99864B/pt not_active IP Right Cessation
- 1991-12-20 HU HU922990A patent/HUT61467A/hu unknown
- 1991-12-20 JP JP92502043A patent/JPH05505830A/ja active Pending
- 1991-12-20 EP EP92901661A patent/EP0516795B1/de not_active Expired - Lifetime
- 1991-12-20 AU AU91397/91A patent/AU655958B2/en not_active Ceased
- 1991-12-20 AT AT92901661T patent/ATE180405T1/de not_active IP Right Cessation
- 1991-12-20 DE DE59109130T patent/DE59109130D1/de not_active Expired - Lifetime
- 1991-12-20 CA CA002076524A patent/CA2076524A1/en not_active Abandoned
- 1991-12-20 IL IL10045891A patent/IL100458A/en not_active IP Right Cessation
- 1991-12-20 WO PCT/DE1991/001006 patent/WO1992011012A1/de active IP Right Grant
- 1991-12-23 IE IE452691A patent/IE914526A1/en unknown
-
1993
- 1993-11-04 US US08/145,720 patent/US6191132B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IL100458A0 (en) | 1992-09-06 |
JPH05505830A (ja) | 1993-08-26 |
WO1992011012A1 (de) | 1992-07-09 |
DE59109130D1 (de) | 1999-07-01 |
IL100458A (en) | 1996-12-05 |
CA2076524A1 (en) | 1992-06-21 |
HU9202990D0 (en) | 1992-12-28 |
IE914526A1 (en) | 1992-07-01 |
US6191132B1 (en) | 2001-02-20 |
EP0516795A1 (de) | 1992-12-09 |
AU655958B2 (en) | 1995-01-19 |
PT99864A (pt) | 1992-12-31 |
ATE180405T1 (de) | 1999-06-15 |
PT99864B (pt) | 1999-06-30 |
EP0516795B1 (de) | 1999-05-26 |
AU9139791A (en) | 1992-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG103417A (en) | Condensed pyrimidine bicyclic derivatives | |
MY114926A (en) | N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists | |
HU896762D0 (en) | Process for preparation of pyrimidine-derivatives and for manufacturing of pharmaceutical compositions containing these compounds | |
MY107157A (en) | Quinuclidine derivatives. | |
MX9801305A (es) | Composicion de disolucion rapida oral para agonistas de dopamina. | |
AU3753695A (en) | Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists | |
AU9189301A (en) | Use of substituted imidazo(1,2-A)pyridine-, imidazo(1,2-A)pyrimidine and imidazo(1,2-A)pyrazine-3-YL-amine derivatives for producing NOS-inhibiting medicaments | |
MY137348A (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same | |
HUT71814A (en) | Process for producing pharmaceutical compositions for the treatment of neurological lesions related to traumatic injuries | |
DE69507029T2 (de) | Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten | |
NZ522326A (en) | Adenosine A2A receptor antagonists | |
NZ512339A (en) | New biphenyl and biphenyl-analogous compounds as integrin antagonists | |
UA27749C2 (uk) | Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі | |
HUT61467A (en) | Process for producing pharmaceutical compositions comprising quisqualate receptor antagonist quinoxalinedione and suitable for treating parkinson's disease | |
GEP20033081B (en) | Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas | |
AP2002002697A0 (en) | Biciclic cyclohexylamines and their use as NMDA receptor antagonists. | |
NZ320355A (en) | Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6- tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis | |
AU2001263130A1 (en) | Bicyclic cyclohexylamines and their use as nmda receptor antagonists | |
FR2717812B1 (fr) | Indeno[1,2-e]pyrazine-4-ones, leur préparation et les médicaments les contenant. | |
FR2717813B1 (fr) | Dérivés d'imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant . | |
PL338680A1 (en) | 8-substituted derivatives of 9-h-1,3-dioxolo/4,5-h/2,3-benzoidazepins as inhibitors of ampa/cainate receptors | |
HU9503099D0 (en) | New piperazinyl-alkylthio-pyrimidine derivatives, pharmaceutical compositions containing them, and process for producing the active components | |
IE781877L (en) | DIBENZO £a,d| CYCLOOCTEN-5,12 AND 6,12-IMINES | |
ES483284A1 (es) | Un procedimiento para la preparacion de nuevas dibenzo (a,d)ciclohepten-5,10-iminas sustituidas | |
ES8605518A1 (es) | Procedimiento para preparar derivados de 4-oxo-pirido(2,3-d)pirimidina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFD9 | Temporary protection cancelled due to non-payment of fee |